Back to List View Graph View

PI3K/AKT/mTOR pathway

The PI3K/AKT/mTOR pathway is a central intracellular signaling cascade that regulates cell growth, survival, metabolism, protein synthesis, autophagy, and stress responses.

Where the papers sit

9 papers from the last 6 months study PI3K/AKT/mTOR pathway directly · updated from PubMed 16 Nov 2026

Study type 0 clinical trials · 5 preclinical · 4 unclassified

Themes one subject

Those 9 are all about one subject.

  • Cross-Disease Signaling Research

    Pharmacologic and natural-product modulation of growth, injury, fibrosis, and tissue repair appears across unrelated disease contexts. Studies combine computational prediction, multi-omics, and experimental validation to nominate pathway-targeting compounds and combinations. Reported effects include reduced tumor growth or metastasis, protection from metabolic injury, and improved wound healing. The papers do not support a single disease-specific direction or shared mechanism beyond signaling-pathway involvement.

    9 papers

Papers

The 9 papers from the last 6 months that study PI3K/AKT/mTOR pathway directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Cross-Disease Signaling Research (9)
  1. From in silico prediction to experimental validation: Identification of drugs and novel synergistic combinations that inhibit growth of inflammatory breast cancer cells. PloS one · 16 Sept 2026 PMID 42748134
  2. Alpinia Oxyphylla-Shenqi Siwu Decoction protects against high glucose-induced retinal pigment epithelial cell injury involving the PI3K/AKT/mTOR pathway. International ophthalmology · 10 Sept 2026 PMID 42720704
  3. MXRA5 promotes the progression and metastasis of breast cancer via activation of the epithelial-to-mesenchymal transition pathway. The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 27 Aug 2026 PMID 42657493
  4. Loss of LCN2 Function Ameliorates Glucocorticoid-Induced Muscle Atrophy via Remodeling the Extracellular Matrix. Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 18 Aug 2026 PMID 42610529
  5. Asymmetric hydrogel with "spear-shield" properties promotes diabetic foot ulcer healing by modulating macrophage autophagy. Journal of controlled release : official journal of the Controlled Release Society · 6 Jul 2026 PMID 42409241
  6. Synergistic inhibition of the PI3K-AKT-mTOR signaling pathway in idiopathic pulmonary fibrosis by Sanleng-Ezhu: a multi-omics and experimental study. Functional & integrative genomics · 26 Jun 2026 PMID 42362788
  7. Antitumor effect of the AP5Z1 small-molecule inhibitor PGG in hepatocellular carcinoma. Medical oncology (Northwood, London, England) · 25 Jun 2026 PMID 42347921
  8. High intrapancreatic fat deposition accelerates pancreatic ductal adenocarcinoma growth and metastasis with enrollment of FABP5 upregulation. Scientific reports · 6 Jun 2026 PMID 42251134
  9. Integrative Database-Driven In Silico and In Vitro Study of Anemarrhena asphodeloides Bunge Highlighting Hippeastrine as a Regulator of the HSP90/PI3K/Akt/mTOR Axis in Oral Squamous Cell Carcinoma. Advanced biology · 30 May 2026 PMID 42216572

By study type

Preclinical: animal, cell and lab studies (5)
  1. From in silico prediction to experimental validation: Identification of drugs and novel synergistic combinations that inhibit growth of inflammatory breast cancer cells. PloS one · 16 Sept 2026 PMID 42748134
  2. Alpinia Oxyphylla-Shenqi Siwu Decoction protects against high glucose-induced retinal pigment epithelial cell injury involving the PI3K/AKT/mTOR pathway. International ophthalmology · 10 Sept 2026 PMID 42720704
  3. Asymmetric hydrogel with "spear-shield" properties promotes diabetic foot ulcer healing by modulating macrophage autophagy. Journal of controlled release : official journal of the Controlled Release Society · 6 Jul 2026 PMID 42409241
  4. Antitumor effect of the AP5Z1 small-molecule inhibitor PGG in hepatocellular carcinoma. Medical oncology (Northwood, London, England) · 25 Jun 2026 PMID 42347921
  5. Integrative Database-Driven In Silico and In Vitro Study of Anemarrhena asphodeloides Bunge Highlighting Hippeastrine as a Regulator of the HSP90/PI3K/Akt/mTOR Axis in Oral Squamous Cell Carcinoma. Advanced biology · 30 May 2026 PMID 42216572
Unclassified: not yet indexed with MeSH (4)
  1. MXRA5 promotes the progression and metastasis of breast cancer via activation of the epithelial-to-mesenchymal transition pathway. The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 27 Aug 2026 PMID 42657493
  2. Loss of LCN2 Function Ameliorates Glucocorticoid-Induced Muscle Atrophy via Remodeling the Extracellular Matrix. Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 18 Aug 2026 PMID 42610529
  3. Synergistic inhibition of the PI3K-AKT-mTOR signaling pathway in idiopathic pulmonary fibrosis by Sanleng-Ezhu: a multi-omics and experimental study. Functional & integrative genomics · 26 Jun 2026 PMID 42362788
  4. High intrapancreatic fat deposition accelerates pancreatic ductal adenocarcinoma growth and metastasis with enrollment of FABP5 upregulation. Scientific reports · 6 Jun 2026 PMID 42251134